Specifically designed to reduce medication costs for patients paying in cash for donor cycles, it’s another way we're helping make treatment more affordable.

Discounted Ferring Fertility Medications for Donor Cycles¹

• Up to 30% discount on BRAVELLE^®

• Significant discounts on MENOPUR^® and ENDOMETRIN^®

HOW THE FERRING DONORx PROGRAM WORKS

• Donor prescriptions must be filled out at a participating pharmacy

• Pharmacy adjudicates prescription as a donor cycle and Ferring DONORx Program pricing discounts applied

• For cash-paying donor prescriptions only

• BRAVELLE^® must be part of the prescription to receive MENOPUR^® and ENDOMETRIN^® discounts

• Maximum of 40 BRAVELLE^® and 30 MENOPUR^® vials within a 30-day period

Click here for a list of participating pharmacies to find the one nearest you.

Click here to see full Prescribing Information for MENOPUR^®, BRAVELLE^®, and ENDOMETRIN^®.

Please see below for Important Rules and Considerations.

IMPORTANT RULES & CONSIDERATIONS

This offer valid for patients paying in cash for MENOPUR^®, BRAVELLE^®, and ENDOMETRIN^® (maximum 70 vials per cycle – 40 vials BRAVELLE^®, 30 vials MENOPUR^®, no limit on ENDOMETRIN^®). Discounts valid for donor cycles only. All discounts contingent upon BRAVELLE^® inclusion in cycle. May not be combined with any other rebate, coupon, or program (ie, the HEART Rx Initiative). This offer is not valid for prescriptions purchased under Medicaid, Medicare, private insurance, or any other federal or state program, or where prohibited by law. No substitutions permitted. Offer good only in the United States. Ferring Pharmaceuticals reserves the right to revoke, rescind, discontinue, or alter this offer without notice.

MENOPUR^® Indication

MENOPUR^® administered subcutaneously is indicated for the development of multiple follicles and pregnancy in the ovulatory patients participating in an ART program.

Important Safety Information

Only physicians thoroughly familiar with infertility treatment, including the risk of multiple births and adverse reactions, should prescribe MENOPUR^®. MENOPUR^®, like all gonadotropins, is a potent substance capable of causing mild to severe adverse reactions, including OHSS (overall incidence 3.8%), with or without pulmonary or vascular complications, in women undergoing therapy for infertility.

BRAVELLE^® Indications

BRAVELLE^® administered SC in conjunction with hCG is indicated for multiple follicular development (controlled ovarian stimulation) during ART cycles in patients who have previously received pituitary suppression. BRAVELLE^® administered SC or IM, in conjunction with hCG, is indicated for ovulation induction in patients who have previously received pituitary suppression.

Important Safety Information

Only physicians thoroughly familiar with infertility treatment, including the risk of multiple births and adverse reactions, should prescribe BRAVELLE^®. BRAVELLE^®, like all gonadotropins, is a potent substance capable of causing mild to severe adverse reactions, including OHSS (incidence 6.0%), with or without pulmonary or vascular complications, in women undergoing therapy for infertility.

ENDOMETRIN^® Indication

ENDOMETRIN^® administered as a progesterone vaginal insert is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment for infertile women.

Important Safety Information

Only physicians thoroughly familiar with infertility treatment should prescribe ENDOMETRIN^®. In clinical trials (n=808), adverse reactions that occurred at a rate greater than or equal to 2% included: uterine spasm (3% to 4%) and vaginal bleeding (3%). Vaginal irritation, itching, burning or discomfort, urticaria, and peripheral edema were reported at an incidence of less than 2%. ENDOMETRIN^® is expected to have adverse reactions similar to other drugs containing progesterone (breast tenderness, bloating, mood swings, irritability, and drowsiness).

REFERENCE: 1. Data on file. Ferring Pharmaceuticals Inc.